Andi Lipstein Fristedt

Fristedt previously served as Deputy Director and Chief Strategy Office at the U.S. Centers for Disease Control and Prevention (CDC). She was the agency's lead policy official and oversaw the agency's expansive global health efforts, communications activities, budget strategy, and overall engagement with Congress and other Washington-based policymakers.

Prior to her time at CDC, Fristedt was the Deputy Commissioner for Policy, Legislation, and International Affairs at the Food and Drug Administration (FDA). Under her leadership, the FDA advanced key policies to bolster medical product regulation, address tobacco use, and strengthen nutrition, food safety and health equity. Fristedt also oversaw agency engagement with Congress in advance of enactment of the Food and Drug Omnibus Reform Act (2022), legislation granting the FDA explicit authority over non-tobacco nicotine products, and increased agency appropriations. Her work at the FDA also focused on strengthening the agency's engagement with Tribal partners and advancing and expanding its global activities.